• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Athira Pharma Inc (NQ: ATHA )

    0.4281 -0.0210 (-4.68%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Athira Pharma Inc

    < Previous 1 2 3 4 5 6 7 8 9 10 Next >
    Exela Technologies (XELA) Stock Soars After Securing $136 Million Contract
    Exela Technologies (XELA) stock is taking off on Wednesday after gaining a new $136 million customer contract that lasts for three years. 
    Via InvestorPlace
    Athira Pharma (ATHA) Stock Plunges 65% on Disappointing Drug Trial Results
    Athira Pharma (ATHA) stock is plummeting on Wednesday following the outcome of a Phase 2 clinical trial of fosgonimeton. 
    Via InvestorPlace
    The Daily Biotech Pulse: Precision BioSciences Inks Gene Editing Pact, Athira Pharma's Alzheimer's Candidate Fails, Enanta Sues Pfizer Over COVID-19 Antiviral
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    Why Athira Pharma Stock Is Plunging
    Athira Pharma Inc (NASDAQ: ATHA) shares are falling Wednesday after the company announced topline results from its exploratory ACT-AD Phase 2 study of fosgonimeton in patients with mild-to-moderate... 
    Via Benzinga
    Athira Pharma Shares Fall To 52-Week Low - Read Why
    Via Benzinga
    ATHIRA PHARMA INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Athira Pharma, Inc. - ATHA
    From Kahn Swick & Foti, LLC
    Via Business Wire
    ATHIRA ALERT: Bragar Eagel & Squire, P.C. Is Investigating Athira Pharma, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire, P.C.
    Via Business Wire
    ATHIRA PHARMA INVESTIGATION CONTINUED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Athira Pharma, Inc. - ATHA
    From Kahn Swick & Foti, LLC
    Via Business Wire
    ATHIRA PHARMA INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Athira Pharma, Inc. - ATHA
    From Kahn Swick & Foti, LLC
    Via Business Wire
    Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2022
    Upgrades 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For April 21, 2022
    Via Benzinga
    ATHIRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Athira Pharma, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire, P.C.
    Via Business Wire
    The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO
    Here's a roundup of top developments in the biotech space over the last 24 hours. 
    Via Benzinga
    The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    Earnings Scheduled For March 24, 2022
    Companies Reporting Before The Bell • iHuman (NYSE:IH) is likely to report earnings for its fourth quarter. • Pioneer Muni High Inc (NYSE:MAV) is expected to... 
    Via Benzinga
    Earnings Preview: Athira Pharma
    Athira Pharma (NASDAQ:ATHA) is set to give its latest quarterly earnings report on Thursday, 2022-03-24. Here's what investors need to know before the announcement. Analysts... 
    Via Benzinga
    The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings
    Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment... 
    Via Benzinga
    35 Stocks Moving In Friday's Mid-Day Session
    Gainers Phunware, Inc. (NASDAQ: PHUN) rose 1099% to $18.35. Phunware shares jumped over 45% on Thursday, possibly in sympathy with Digital World Acquisition as traders circulated... 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021
    Upgrades B of A Securities upgraded the previous rating for ONE Gas Inc (NYSE: 
    Via Benzinga
    Athira CEO Resigns After Data Manipulation Firestorm, But Alzheimer's Stock Pops
    Athira CEO Leen Kawas resigned after an investigation found she altered images. 
    Via Investor's Business Daily
    Why Shares of Athira Pharma Are Climbing Today
    The clinical trial for its Alzheimer's drug is one step closer to completion. 
    Via The Motley Fool
    The Daily Biotech Pulse: Athira CEO Resigns Over Doctored Research, Merck's Keytruda Snags First Approval For Breast Cancer In Europe, Minerva And Xilio IPOs
    Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Athira Names Chief Operating Officer Mark Litton As Next CEO as Leen Kawas... 
    Via Benzinga
    Rebuilding Connections, Fostering Growth: Synaptogenix Could Be A Beacon of Hope for Patients With Neurological Diseases
    Image by Gerd Altmann from Pixabay How well we think, feel and act rests in the hands of trillions of tiny connectors in our minds. Synapses play an integral role in how we... 
    Via Benzinga
    NASDAQ:ATHA Long Term Investor Notice: Investigation of Potential Wrongdoing at Athira Pharma, Inc.
    San Diego, CA -- (SBWIRE) -- 10/01/2021 -- An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Athira Pharma, Inc. 
    Via SBWire
    Topics Intellectual Property Lawsuit
    Exposures Financial Intellectual Property Legal
    ATHIRA SHAREHOLDER NOTICE
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Initial Public Offering Intellectual Property Lawsuit
    Exposures Financial Intellectual Property Legal
    ATHIRA SHAREHOLDER ALERT
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Initial Public Offering Intellectual Property Lawsuit
    Exposures Financial Intellectual Property Legal
    ATHIRA DEADLINE ALERT
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Initial Public Offering Intellectual Property Lawsuit
    Exposures Financial Intellectual Property Legal
    CLASS ACTION UPDATE for ATHA, OTLY and AHCO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
    NEW YORK, NY / ACCESSWIRE / August 24, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies.... 
    From Levi & Korsinsky, LLP
    Via AccessWire
    Topics Intellectual Property Lawsuit
    Exposures Financial Intellectual Property Legal
    Last Day for Shareholders to Actively Participate in Athira Pharma, Inc. (ATHA) Class Action: Bronstein, Gewirtz & Grossman, LLC
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Athira Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal
    < Previous 1 2 3 4 5 6 7 8 9 10 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.